Founded in Shanghai and Suzhou, CStone PharmaceuticalsCo. Ltd is not your normal Chinese biopharma startup – it seems to have all the ingredients for success, all come together, in no time.
Record CStone Funding Heralds New Era For China Startups
With $150m in hand and a pipeline covering five therapeutic areas, CStone has already broken the record for the largest Series A investment in a Chinese biopharma startup. If that's not impressive enough, add a CEO from big pharma and support from China’s largest CRO.